- Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024
- Haemonetics Receives FDA Clearance for New TEG® 6s Global Hemostasis - HN Cartridge
- Haemonetics Corporation Completes Acquisition of Attune Medical
- Haemonetics Announces Definitive Agreement to Acquire Attune Medical
- Haemonetics to Present at Raymond James 45th Annual Institutional Investors Conference
- Haemonetics to Present at Citi's 2024 Unplugged Medtech and Life Sciences Access Day
- Haemonetics 3rd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website
More ▼
Key statistics
On Wednesday, Haemonetics Corp (HAE:NYQ) closed at 86.22, -9.49% below its 52-week high of 95.26, set on Aug 08, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 84.07 |
---|---|
High | 86.30 |
Low | 83.60 |
Bid | 82.97 |
Offer | 88.63 |
Previous close | 85.07 |
Average volume | 465.90k |
---|---|
Shares outstanding | 50.79m |
Free float | 50.40m |
P/E (TTM) | 34.42 |
Market cap | 4.32bn USD |
EPS (TTM) | 2.47 USD |
Data delayed at least 15 minutes, as of Apr 24 2024 23:30 BST.
More ▼